Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 04 02:15PM ET
17.05
Dollar change
+0.61
Percentage change
3.71
%
IndexRUT P/E- EPS (ttm)-3.15 Insider Own47.43% Shs Outstand91.50M Perf Week7.98%
Market Cap1.56B Forward P/E- EPS next Y-4.33 Insider Trans-0.00% Shs Float48.11M Perf Month9.58%
Income-270.00M PEG- EPS next Q-1.25 Inst Own54.45% Short Float15.74% Perf Quarter5.57%
Sales263.00M P/S5.93 EPS this Y19.56% Inst Trans5.88% Short Ratio10.66 Perf Half Y4.73%
Book/sh6.17 P/B2.76 EPS next Y-29.80% ROA-22.10% Short Interest7.57M Perf Year5.90%
Cash/sh11.90 P/C1.43 EPS next 5Y7.80% ROE-49.77% 52W Range13.52 - 20.31 Perf YTD-10.73%
Dividend Est.- P/FCF- EPS past 5Y-23.70% ROI-44.12% 52W High-16.05% Beta0.85
Dividend TTM- Quick Ratio5.23 Sales past 5Y164.80% Gross Margin95.44% 52W Low26.11% ATR (14)1.02
Dividend Ex-Date- Current Ratio5.23 EPS Y/Y TTM21.18% Oper. Margin-113.31% RSI (14)59.12 Volatility7.25% 6.63%
Employees577 Debt/Eq0.10 Sales Y/Y TTM119.80% Profit Margin-102.66% Recom1.64 Target Price32.80
Option/ShortYes / Yes LT Debt/Eq0.08 EPS Q/Q-5.77% Payout- Rel Volume0.72 Prev Close16.44
Sales Surprise23.23% EPS Surprise5.33% Sales Q/Q50.00% EarningsNov 06 AMC Avg Volume710.49K Price17.05
SMA207.90% SMA504.66% SMA2004.13% Trades Volume382,985 Change3.71%
Date Action Analyst Rating Change Price Target Change
Oct-21-24Initiated H.C. Wainwright Neutral $20
Oct-08-24Initiated Wells Fargo Overweight $29
Nov-18-22Initiated BofA Securities Neutral $33
Oct-11-22Initiated Morgan Stanley Overweight $40
Oct-15-21Resumed BTIG Research Buy $57
Nov-24-20Initiated Berenberg Buy $50
Nov-23-20Initiated Evercore ISI Outperform
Apr-03-20Initiated Cantor Fitzgerald Overweight $21
Mar-04-20Initiated Barclays Overweight $24
Nov-12-19Initiated SunTrust Buy $20
Dec-03-24 04:35PM
Dec-02-24 10:18AM
Nov-19-24 04:05PM
Nov-12-24 04:35PM
Nov-07-24 02:26AM
05:35PM Loading…
Nov-06-24 05:35PM
04:22PM
Nov-05-24 09:00AM
07:48AM
Oct-30-24 10:01AM
09:00AM
Oct-24-24 04:35PM
07:30AM
Oct-22-24 04:05PM
Oct-17-24 03:02PM
06:03PM Loading…
Oct-09-24 06:03PM
04:35PM
08:00AM
Oct-02-24 04:05PM
Sep-24-24 04:35PM
Sep-10-24 04:35PM
Aug-28-24 02:33PM
Aug-27-24 04:05PM
Aug-26-24 04:35PM
Aug-21-24 04:05PM
Aug-16-24 04:52AM
Aug-08-24 06:15PM
04:05PM
Aug-01-24 10:01AM
08:00AM
04:05PM Loading…
Jul-25-24 04:05PM
Jul-09-24 04:35PM
06:32AM
Jul-08-24 06:00PM
Jun-25-24 04:35PM
Jun-11-24 04:35PM
Jun-10-24 08:30AM
Jun-07-24 10:55AM
Jun-06-24 04:05PM
Jun-02-24 08:00AM
Jun-01-24 08:00AM
May-24-24 04:35PM
May-10-24 01:38PM
May-09-24 04:35PM
03:48PM
03:47AM
May-08-24 09:59PM
05:45PM
04:02PM
May-02-24 04:05PM
May-01-24 10:01AM
Apr-24-24 04:00PM
Apr-23-24 04:05PM
Apr-09-24 04:35PM
Mar-29-24 07:01PM
Mar-26-24 04:35PM
Mar-20-24 07:00PM
Mar-11-24 04:35PM
Feb-29-24 03:14AM
Feb-28-24 04:05PM
Feb-27-24 04:35PM
Feb-22-24 11:10AM
09:55AM
07:16AM
Feb-21-24 04:37PM
04:05PM
Feb-09-24 04:35PM
Feb-07-24 05:00PM
Feb-05-24 12:59PM
Jan-29-24 05:00PM
Jan-26-24 04:35PM
Jan-16-24 05:00PM
Dec-11-23 04:35PM
Dec-04-23 08:00AM
Nov-27-23 04:35PM
Nov-14-23 04:00PM
Nov-13-23 04:35PM
Nov-08-23 04:05PM
Nov-07-23 04:01PM
Nov-06-23 05:00PM
Oct-31-23 10:01AM
Oct-24-23 04:35PM
Oct-17-23 04:00PM
Oct-10-23 04:35PM
Sep-27-23 05:14AM
Sep-26-23 04:35PM
Sep-11-23 04:35PM
Sep-05-23 07:37PM
Aug-24-23 04:35PM
11:30AM
09:02AM
Aug-23-23 11:39AM
09:00AM
Aug-09-23 04:35PM
Aug-07-23 09:15AM
08:00AM
Aug-03-23 05:55PM
Aug-02-23 05:25PM
Aug-01-23 05:45PM
Jul-25-23 04:35PM
Arcus Biosciences, Inc. engages in the development and commercialization of immunotherapies. It competes in the segments of the pharmaceutical, biotechnology and other related markets that develop immunotherapies for the treatment of cancer. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Azoy AlexanderChief Accounting OfficerAug 13 '24Sale14.971,35720,31419,070Aug 15 04:45 PM
Jarrett JenniferChief Operating OfficerMar 27 '24Sale17.5511,551202,720215,253Mar 29 04:20 PM
Jarrett JenniferChief Operating OfficerMar 18 '24Sale17.9213,449240,941226,804Mar 20 04:19 PM
Jarrett JenniferChief Operating OfficerFeb 27 '24Sale20.1134,070685,148240,253Feb 28 07:55 PM
Jarrett JenniferChief Operating OfficerFeb 26 '24Sale20.0724,555492,819274,323Feb 28 07:55 PM
Jaen Juan C.PresidentFeb 27 '24Sale20.1023,132464,9531,188,233Feb 28 07:55 PM
Jaen Juan C.PresidentFeb 26 '24Sale20.063,90078,2341,211,365Feb 28 07:55 PM
GILEAD SCIENCES, INC.10% OwnerJan 29 '24Buy21.0015,238,095319,999,99530,061,124Jan 31 05:00 PM
Goeltz II Robert C.Chief Financial OfficerJan 02 '24Sale20.002,00440,08051,831Jan 04 05:23 PM
Jaen Juan C.PresidentJan 02 '24Sale20.096,975140,1281,215,265Jan 04 05:22 PM
Jarrett JenniferChief Operating OfficerDec 22 '23Sale17.7621,521382,213258,878Dec 26 04:04 PM